… of Ebrantil®, Edarbi®, Basen®, Blopress® and Actos®. Employees dedicated to … ecosystem to bring life-changing treatments to chronic disease patients.… the healthcare sector, including pharmaceutical and biotech, medical technology and healthcare services. …

… products include Actos, Amoclan, Blopress, Omnicef, Prograf, and Suprax. … product is on the FDA's drug shortage list in the … essential product for the treatment of COVID-19 in … CEO) and Teva Pharmaceutical (CEO of global generic medicines). What is often …

… the commercial rights to drugs in various chronic diseases … including Edarbi®, Basen®, Actos®, Blopress®, and Nesina®. Fu Wei, … vision of addressing unmet medical needs across communities … special offers from American Pharmaceutical Review – all delivered …

… with commercial rights to treatments in various chronic disease … include Edarbi®, Basen®, Actos®, Blopress® and Nesina®, spanning across 8 … across the healthcare space, including pharmaceutical, biotech, medical technology, and healthcare services. Founded …

… with the commercial rights to drugs in various chronic diseases areas … , including Edarbi®, Basen®, Actos®, Blopress®, and Nesina®. Fu Wei, CEO … across the healthcare space, including pharmaceutical, biotech, medical technology, and healthcare services. We …

… with commercial rights to treatments in various chronic disease … include Edarbi®, Basen®, Actos®, Blopress® and Nesina®, spanning across 8 … across the healthcare space, including pharmaceutical, biotech, medical technology, and healthcare services. Founded …

… unmet medical need/orphan disease where US biotech has … regulatory environment for Regenerative Medicine Drug Development and Drug Repurposing will make … coming time. Successful launch of Blopress AG, Plavix AG in … 353-1-481-1716 Sector: Pharmaceuticals

… acquisition with commercial rights to treatments in various chronic disease areas … . These include Edarbi, Basen, Actos, Blopress and Nesina, spanning across 8 …